Hirschsprung's disease medical therapy

Hirschsprung's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hirschsprung's Disease from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory findings
Electrocardiogram
X-ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary prevention
Secondary prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hirschsprung's disease medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hirschsprung's disease medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hirschsprung's disease medical therapy
CDC on Hirschsprung's disease medical therapy
Hirschsprung's disease medical therapy in the news
Blogs on Hirschsprung's disease medical therapy
Directions to Hospitals Treating Hirschsprung's disease
Risk calculators and risk factors for Hirschsprung's disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medications only play a supportive role in the management of Hirschsprung's disease. They are indicated to prevent complications of Hirschsprung disease, to prevent infections during reconstructive surgery, and to manage postoperative bowel function. Intravenous fluid resuscitation and maintenance, nasogastric decompression, and administration of intravenous antibiotics (as indicated) remain the cornerstones of initial medical management.